Search
Now showing items 1-8 of 8
The expression of P21 in esophageal carcinoma cells was enhanced by combination of 7-geranyloxycoumarin and paclitaxel
coumarin derivative with
various biological properties. In present study, we investigated 7-geranyloxycoumarin
effects on the cytotoxicity of a common anticancer agent, paclitaxel, which induced
P21-dependent apoptosis...
Increased Cytotoxicity of Paclitaxel and 5-Fluorouracil in Stem-Like KYSE30 Cells by Combination with Auraptene
Carcinoma (ESCC), is mainly due to their poor diagnosis and inefficacy of current therapeutic strategies. Paclitaxel and 5-fluorouracil are two anticancer agents commonly prescribed for ESCC. To investigate whether natural compounds...
Increased Cytotoxicity of Paclitaxel and 5-Fluorouracil in Stem-Like KYSE30 Cells by Combination with Auraptene
(ESCC), is mainly due to their poor diagnosis and inefficacy of current therapeutic strategies.Paclitaxel and 5-fluorouracil are two anticancer agents commonly prescribed for ESCC. To investigate whether natural compounds such as coumarins could enhance...
Investigating Synergic Effects of Valproic Acid on Anticancer Agents in Vitro
VPA effects on the toxicity of chemotherapy drugs, cisplatin, paclitaxel and 5-fluorouracil, using esophageal cancer cells(KYSE30 cell line). Materials and Methods: To determine the half maximal inhibitory concentration (IC50) of VPA, HFF3 cells, human...
Investigating the synergistic effects of sesquiterpene lactone cynaropicrinin combination with chemotherapy drug, paclitaxel on KYSE30 human esophageal carcinoma cells
Drug combination is often applied to increase the effectiveness of treatment for specific and severe illnesses, such as cancer. So far various approaches have been designed to identify the effects of each drug when used ...